NL6813543A - - Google Patents

Info

Publication number
NL6813543A
NL6813543A NL6813543A NL6813543A NL6813543A NL 6813543 A NL6813543 A NL 6813543A NL 6813543 A NL6813543 A NL 6813543A NL 6813543 A NL6813543 A NL 6813543A NL 6813543 A NL6813543 A NL 6813543A
Authority
NL
Netherlands
Application number
NL6813543A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6813543A publication Critical patent/NL6813543A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL6813543A 1967-09-26 1968-09-21 NL6813543A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR122284 1967-09-26

Publications (1)

Publication Number Publication Date
NL6813543A true NL6813543A (enExample) 1969-03-28

Family

ID=8638987

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6813543A NL6813543A (enExample) 1967-09-26 1968-09-21

Country Status (10)

Country Link
US (1) US3608071A (enExample)
AT (1) AT282822B (enExample)
BE (1) BE721141A (enExample)
CH (1) CH492786A (enExample)
DE (1) DE1792600A1 (enExample)
DK (1) DK122970B (enExample)
FR (1) FR1604134A (enExample)
GB (1) GB1243383A (enExample)
LU (1) LU56939A1 (enExample)
NL (1) NL6813543A (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181426B1 (enExample) * 1972-04-06 1974-12-20 Pasteur Institut
US4016252A (en) * 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
FR2227861B1 (enExample) * 1973-05-04 1976-07-02 Anvar
US3874999A (en) * 1973-10-31 1975-04-01 American Cyanamid Co Process for the purification of virus vaccine
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
EP1615596B1 (en) * 2003-04-11 2016-11-02 Etex Corporation Osteoinductive bone material
AU2004249802B2 (en) * 2003-06-20 2007-06-28 Microbix Biosystems Inc. Improvements in virus production
KR101218454B1 (ko) * 2004-04-15 2013-01-04 에텍스 코포레이션 세팅 지연 칼슘 포스페이트 페이스트
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material

Also Published As

Publication number Publication date
US3608071A (en) 1971-09-21
DK122970B (da) 1972-05-01
AT282822B (de) 1970-07-10
LU56939A1 (enExample) 1969-01-04
DE1792600A1 (de) 1971-11-25
CH492786A (fr) 1970-06-30
BE721141A (enExample) 1969-03-03
GB1243383A (en) 1971-08-18
FR1604134A (enExample) 1971-07-12

Similar Documents

Publication Publication Date Title
FR1604134A (enExample)
AU610966A (enExample)
BE699495A (enExample)
BE701410A (enExample)
BE709873A (enExample)
BE708941A (enExample)
BE709568A (enExample)
BE707886A (enExample)
BE708135A (enExample)
BE700560A (enExample)
BE709383A (enExample)
BE704378A (enExample)
BE709017A (enExample)
BE706909A (enExample)
BE708430A (enExample)
BE707177A (enExample)
BE709546A (enExample)
BE710370A (enExample)
BE708814A (enExample)
BE710727A (enExample)
BE702292A (enExample)
BE707772A (enExample)
BE708547A (enExample)
BE709635A (enExample)
BE709292A (enExample)